Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TAPT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TAPT1-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PROM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FGFBP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FGFBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD38 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BST1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LDB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM200B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929123 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929143 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
QDPR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LAP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on